IVERIC bio, Inc. Operating Lease, Expense
IVERIC bio, Inc. reported Operating Lease, Expense of $400.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-05-10
- IVERIC bio, Inc. operating lease, expense for the quarter ending 2023-03-31 was $400.00K, a 33.33% increase year-over-year.
- IVERIC bio, Inc. operating lease, expense for the quarter ending 2022-12-31 was $500.00K.
- IVERIC bio, Inc. operating lease, expense for the quarter ending 2022-09-30 was $400.00K.
- IVERIC bio, Inc. operating lease, expense for the quarter ending 2022-06-30 was $200.00K.
- IVERIC bio, Inc. operating lease, expense for fiscal 2022 was $1.40M, a 100.00% increase from fiscal 2021.
- IVERIC bio, Inc. operating lease, expense for fiscal 2021 was $700.00K, a 16.67% increase from fiscal 2020.
- IVERIC bio, Inc. operating lease, expense for fiscal 2020 was $600.00K, a 40.00% decline from fiscal 2019.
- IVERIC bio, Inc. operating lease, expense for fiscal 2019 was $1.00M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2023-03-31 | $400.00K 10-Q · filed 2023-05-10 | $900.00K derived: sum of 2 quarters · filed 2023-05-10 | $1.30M derived: sum of 3 quarters · filed 2023-05-10 | $1.50M derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $900.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.10M derived: sum of 3 quarters · filed 2023-03-01 | $1.40M 10-K · filed 2023-03-01 |
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-04 | $600.00K derived: sum of 2 quarters · filed 2022-11-04 | $900.00K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $200.00K 10-Q · filed 2022-07-26 | $500.00K 10-Q · filed 2022-07-26 | ||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $700.00K 10-K · filed 2023-03-01 | |||
| 2020-12-31 | $600.00K 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $500.00K derived: sum of 2 quarters · filed 2022-02-24 | $800.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.00M 10-K · filed 2022-02-24 |
| 2019-09-30 | $300.00K 10-Q · filed 2019-11-12 | $600.00K derived: sum of 2 quarters · filed 2019-11-12 | $800.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $300.00K 10-Q · filed 2019-08-01 | $600.00K 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $300.00K 10-Q · filed 2019-05-08 |